Introducing Sygnia Itrix Solactive Healthcare 150 ETF: pioneering health innovation investment, capturing Covid-19 vaccine frontrunners and leading healthcare innovators.
Meet the ETF that puts health innovation at its heart! We are proud to announce the launch of the Sygnia Itrix Solactive Healthcare 150 ETF as part of Sygnia's award-winning Itrix range of ETFs.
The coronavirus pandemic has shown us how essential healthcare is to global prosperity, and the Sygnia Itrix Solactive Healthcare 150 ETF is perfectly positioned to benefit from the accelerated growth in this sector. The fund’s top holdings include a number of Covid-19 vaccine frontrunners and some of the largest and most innovative companies rethinking global healthcare today.
The objective of this ETF is to provide an investment vehicle that gives easy access to investors who want to achieve long term capital appreciation in tracking the performance of the Solactive Developed Markets Healthcare 150 Index (.SDMH150P) (“benchmark index”). The Fund has a 100% strategic allocation to global equities. The risk in the Fund is managed by spreading investments across countries and individual shares.